Up slightly this morning $1.83 on more than 3800 trades and crossing 1 million shares of volume. [mstock id="73007" asset="MDWD"] MediWound Announces Positive Results from its U.S. Phase 2 Pharmacology Study of EscharEx for Debridement of Lower Leg Ulcers https://www.globenewswire.com/news-release/2022/07/07/2475710/30505/en/MediWound-Announces-Positive-Results-from-its-U-S-Phase-2-Pharmacology-Study-of-EscharEx-for-Debridement-of-Lower-Leg-Ulcers.html